13.2 ALPP Code of Ethics: Commercial Product Reporting & WHO Code Violations

Why This Topic Matters

ALPP's Code of Ethics is not a set of abstract aspirations — it is a binding professional standard enforced by a real Disciplinary Review Panel that can suspend or permanently revoke a CLC credential. On the exam, this topic surfaces as scenario questions that quietly embed a conflict of interest, a confidentiality lapse, or a marketing violation inside an otherwise ordinary clinical situation, then ask what the CLC should do. Getting comfortable with the Code's structure — and with the WHO Code specifically — turns those scenarios from guesswork into recognition.

The Seven Pillars of the ALPP Code of Ethics

The CLC Candidate Handbook organizes its Code of Ethics into seven named principles, each with specific lettered standards. Knowing the pillar names helps you match an exam scenario to the right underlying rule:

Two pillars are frequently confused by exam distractors: Justice governs refusing a gift from a current client (to avoid the appearance of favoritism), while Role Fidelity governs disclosing a financial conflict of interest with a company (to keep clinical judgment commercially neutral). Both involve "gifts," but the source and the ethical concern are different.

The WHO International Code of Marketing of Breast-milk Substitutes

Adopted by the World Health Assembly in 1981, the WHO Code restricts how formula, bottle, and teat manufacturers market their products so that a family's feeding decisions are shaped by health information, not marketing pressure. Under Nonmaleficence standard P, a CLC must "abide by the International Code of Marketing of Breast-Milk Substitutes and subsequent resolutions which pertain to health workers." Under Scope of Practice item #12, a CLC is expected to identify and recognize violations of the Code.

The ALPP Handbook names concrete, exam-testable examples of violations a CLC should be able to spot:

• Powdered infant formula advertisements displayed in a healthcare setting.
• Sponsored social media posts promoting formula brands.
• Incorrect (or misleadingly simplified) preparation instructions on powdered infant formula can labels.
• Free samples, gifts, or product supplies given to health workers or facilities by manufacturers.
• Direct contact between company representatives and mothers promoting a brand.

A CLC's duty is to recognize these as Code violations and decline to participate (for example, refusing to distribute company literature or branded discharge bags) — not to act as a private enforcement agency. The exam rewards "recognizes and does not participate," not overreach like "confronts the company representative" or "reports it to a government regulator."

Commercial Product Conflict-of-Interest Rules

Separately from WHO Code recognition, the Code of Ethics requires CLCs to manage their own commercial relationships honestly:

• Disclose any financial or other conflict of interest with companies providing goods or services (Role Fidelity, standard Q).
• Ensure professional judgment is never influenced by commercial considerations — a CLC does not recommend a specific pump or product brand because of a sponsorship.
• Carry adequate liability insurance when providing services or products.
• Respect intellectual property (copyrights, trademarks) when using educational materials.

Example: A breast pump manufacturer offers a CLC free product samples and a stipend to feature their brand exclusively in patient handouts. The correct response is to disclose the relationship and either decline to let it shape clinical recommendations, or decline the arrangement altogether — not to quietly accept it because "the products are good."

Reporting Mechanism & Disciplinary Process

ALPP's enforcement path, directly from the Candidate Handbook, is a specific sequence the exam can test:

1. A complaint is filed using the Concerns and Complaints Submission Form — it must be signed with the complainant's name, phone, and address (ALPP does not accept anonymous submissions), though that identifying information is never shared with the accused.
2. ALPP's Director of Operations and Certification Director first review the complaint and attempt resolution.
3. If unresolved, it escalates to the Disciplinary Review Panel (quorum of 3, decisions by majority vote).
4. The candidate/Certificant is notified of the alleged violation and has 15 days to request an oral hearing or comment on sanctions; failure to respond means the allegation is treated as true.
5. Possible sanctions include denial or suspension of exam eligibility, suspension or revocation of CLC Certification, censure, reprimand, and required corrective training.
6. A final decision may be appealed within 30 days to the Appeals Board, whose decision is final.

Realistic Exam Scenarios

Scenario 1: A CLC notices that every discharging family on the postpartum unit — regardless of feeding choice — receives a branded tote bag from a formula company featuring cartoon babies. This is a facility-level WHO Code violation (free promotional gifts distributed through a healthcare setting). The CLC's correct action is to recognize it as a violation and decline to participate in distributing the bags.

Scenario 2: A mother who is still an active client offers her CLC a $200 gift card as a thank-you. Under the Justice pillar, the CLC should politely decline while the counseling relationship is ongoing, to avoid any appearance of seeking preferential treatment.

Scenario 3: A bottle manufacturer invites a CLC to a paid "brand ambassador" program in exchange for recommending its products to clients. The Role Fidelity pillar requires disclosure of this relationship and keeping clinical recommendations free of commercial influence.

Common Traps

• Anonymous complaints are not accepted by ALPP — a frequently missed, specific detail (identity is required, but kept confidential from the accused).
• Mixing up pillars: a scenario about a gift from a client tests Justice; a scenario about a financial tie to a company tests Role Fidelity.
• Overreach answers that have the CLC "reporting the company to the government" or "publicly confronting" violators go beyond the CLC's actual recognize-and-decline-to-participate role.